Substance Use Disorders Are Under-Recognized in Patients With Diabetes
The Carlat Addiction Treatment Report, Volume 6, Number 5, July 2018
Rehan Aziz, MD
Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Type 2 diabetes (T2D) is a common condition with high treatment costs and significant morbidity and mortality. In 2015, an estimated 30.2 million American adults had T2D. Diabetes can be comorbid with other behavioral health disorders (BHDs), and this can lead to additional costs and increased morbidity and mortality risk.